文献速递流行病学与生物统计基础与转化研究

连续与二分类结局的单阶段个体参与者数据荟萃分析模型:治疗编码选项与估计方法的比较

One-stage individual participant data meta-analysis models for continuous and binary outcomes: Comparison of treatment coding options and estimation methods.
PubMed 文献 · Stat Med · 2020-05-11

该研究通过模拟评估单阶段个体参与者数据荟萃分析模型在连续或二分类结局随机试验中的表现,比较限制最大似然(REML)与最大似然(ML)估计。关键发现:基于t分布的推断改善治疗效应置信区间覆盖;ML估计分层截距模型时治疗变量应采用研究特异性中心化编码以减少组间方差估计偏倚;REML相比ML减少组间方差低估偏倚且不依赖治疗编码。

要点

  • 基于t分布的推断比z分布改善治疗效应置信区间覆盖。
  • ML估计分层截距模型时,治疗变量采用研究特异性中心化编码减少组间方差偏倚。
  • REML估计减少组间方差低估偏倚,不依赖治疗编码,但二分类结局需伪似然REML且可能不稳定。

核心结论

  • 对于单阶段IPD荟萃分析,基于t分布的推断通常改善治疗效应置信区间覆盖。
  • ML估计分层截距模型时,治疗变量采用研究特异性中心化编码可减少组间方差估计偏倚。
  • REML估计相比ML减少组间方差低估偏倚,且不依赖治疗变量编码。

研究设计与样本

  • 研究采用模拟评估REML和ML估计单阶段IPD荟萃分析模型的性能。
  • 模拟场景为合成连续或二分类结局的随机试验。

主要发现

  • 对于ML或REML估计的分层截距或随机截距模型,t分布方法通常改善治疗效应置信区间覆盖。
  • ML估计分层截距模型时,研究特异性中心化编码相比1/0及其他编码减少组间方差估计偏倚。
  • REML估计减少组间方差低估偏倚,且不依赖治疗变量编码。
  • 二分类结局需REML估计伪似然,但在数据稀疏等情况下可能不稳定。

临床怎么用

  • 在单阶段IPD荟萃分析中,优先考虑基于t分布的推断以改善置信区间覆盖。
  • 若使用ML估计分层截距模型,治疗变量应采用研究特异性中心化编码。
  • 为减少组间方差低估偏倚,可选用REML估计,但二分类结局需注意伪似然REML的稳定性。

局限性

  • 二分类结局的REML估计伪似然在某些情况下(如数据稀疏)可能不稳定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A one-stage individual participant data (IPD) meta-analysis synthesizes IPD from multiple studies using a general or generalized linear mixed model. This produces summary results (eg, about treatment effect) in a single step, whilst accounting for clustering of participants within studies (via a stratified study intercept, or random study intercepts) and between-study heterogeneity (via random treatment effects). We use simulation to evaluate the performance of restricted maximum likelihood (REML) and maximum likelihood (ML) estimation of one-stage IPD meta-analysis models for synthesizing randomized trials with continuous or binary outcomes. Three key findings are identified. First, for ML or REML estimation of stratified intercept or random intercepts models, a t-distribution based approach generally improves coverage of confidence intervals for the summary treatment effect, compared with a z-based approach. Second, when using ML estimation of a one-stage model with a stratified intercept, the treatment variable should be coded using "study-specific centering" (ie, 1/0 minus the study-specific proportion of participants in the treatment group), as this reduces the bias in the between-study variance estimate (compared with 1/0 and other coding options). Third, REML estimation reduces downward bias in between-study variance estimates compared with ML estimation, and does not depend on the treatment variable coding; for binary outcomes, this requires REML estimation of the pseudo-likelihood, although this may not be stable in some situations (eg, when data are sparse). Two applied examples are used to illustrate the findings.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Riley RD, Legha A, Jackson D, et al. One-stage individual participant data meta-analysis models for continuous and binary outcomes: Comparison of treatment coding options and estimation methods. Stat Med. 2020. PMID: 32394498. doi:10.1002/sim.8555

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。